T H Landowski - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001

Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cellsM M Oshiro, T H Landowski, R Catlett-Falcone, et al.

Leukemia|February 20, 2003

The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cellsS C E Bolick, T H Landowski, D Boulware, et al.

Immunity|February 19, 1999

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cellsR Catlett-Falcone, T H Landowski, M M Oshiro, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001

Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cellsM M Oshiro, T H Landowski, R Catlett-Falcone, et al.

Leukemia|February 20, 2003

The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cellsS C E Bolick, T H Landowski, D Boulware, et al.

Immunity|February 19, 1999

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cellsR Catlett-Falcone, T H Landowski, M M Oshiro, et al.

Pageof 2